Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable”

190 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 190 results

Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Not applicableUnknownNCT04855331
What this trial is testing

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

Who this might be right for
Borderline Resectable Pancreatic Cancer
Fudan University 120
Testing effectiveness (Phase 2)Looking for participantsNCT06904014
What this trial is testing

Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC

Who this might be right for
HCC
Lei ZHAO 40
Testing effectiveness (Phase 2)Study completedNCT03983057
What this trial is testing

Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Zhejiang University 392
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07208539
What this trial is testing

AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Shanghai Zhongshan Hospital 77
Testing effectiveness (Phase 2)UnknownNCT02926183
What this trial is testing

Study of NAC of GA Therapy for Patients With BRPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Wakayama Medical University 60
Testing effectiveness (Phase 2)Study completedNCT02676349
What this trial is testing

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Who this might be right for
Pancreatic Carcinoma
Institut de Cancérologie de Lorraine 130
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00833859
What this trial is testing

Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07283991
What this trial is testing

QL1706 Plus Chemotherapy for Borderline Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Ruijin Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT05083247
What this trial is testing

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmPancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
Erasme University Hospital 256
Testing effectiveness (Phase 2)Looking for participantsNCT05825066
What this trial is testing

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Wake Forest University Health Sciences 64
Not applicableStudy completedNCT02336672
What this trial is testing

EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study)

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
IRCCS San Raffaele 66
Testing effectiveness (Phase 2)Ended earlyNCT01359007
What this trial is testing

FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of Pancreas
University of Oklahoma 5
Testing effectiveness (Phase 2)Study completedNCT00761241
What this trial is testing

Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT

Who this might be right for
Pancreatic Cancer
Benaroya Research Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT07542002
What this trial is testing

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Who this might be right for
Pancreatic Cancer
Ningbo Medical Center Lihuili Hospital 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616362
What this trial is testing

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 110
Testing effectiveness (Phase 2)Ended earlyNCT01531712
What this trial is testing

Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable

Who this might be right for
Pancreatic Cancer
Institut Català d'Oncologia 6
Not applicableStudy completedNCT05514171
What this trial is testing

Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline

Who this might be right for
Chemotherapy EffectPancreas Cancer
Hospital del Mar 300
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Next Page